The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 2, 2000, Pages 347-351

  Lee, Susan C ^a   Yoburn, Byron C ^a  

^a St Albert's Hall   (United States)

Author keywords

Opioid receptor regulation; Analgesia; Calcium channel blocker; Morphine; Naltrexone; Nimodipine; Supersensitivity

Indexed keywords

CALCIUM CHANNEL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; NIMODIPINE; PLACEBO;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SUPERSENSITIVITY; TAIL FLICK TEST;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MICE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NIMODIPINE; RECEPTORS, OPIOID, MU; UP-REGULATION;

EID: 0034130646     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00170-2     Document Type: Article

References (34)

1. Benedek G., Szikszay M. Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol. Res. Commun. 16:1984;1009-1018.
2. Ben-Sreti M.M., Gonzalez J.P., Sewell R.D. Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. Eur. J. Pharmacol. 90:1983;385-391.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Contreras E., Tamayo L., Amigo M. Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur. J. Pharmacol. 148:1988;463-466.
5. Del Pozo E., Caro G., Baeyens J.M. Analgesic effects of several calcium channel blockers in mice. Eur. J. Pharmacol. 137:1987;155-160.
6. Del Pozo E., Ruiz-Garcia C., Baeyens J.M. Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test. Gen. Pharmacol. 21:1990;681-685.
7. +1 channels during opioid tolerance and supersensitivity in rats. J. Pharmacol. Exp. Ther. 274:1995;1538-1544.
8. Diaz A., Ruiz F., Florez J., Hurle M.A., Pazos A. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther. 274:1995;1545-1551.
9. Dierssen M., Florez J., Hurle M.A. Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;559-565.
10. Duttaroy A., Yoburn B.C. The effect of intrinsic efficacy on opioid tolerance. Anesthesiology. 82:1995;1226-1236.
11. Duttaroy A., Shen J., Shah S., Chen B., Sehba F., Carroll J., Yoburn B.C. Opioid receptor upregulation in μ-opioid receptor deficient cxbk and outbred Swiss Webster mice. Life Sci. 65:1999;113-123.
12. Finney D.J. Probit analysis. 3rd ed:1973;Cambridge University Press, London.
13. +1 uptake. J. Pharmacol. Exp. Ther. 209:1979;132-136.
14. Guerrero-Munoz F., Guerrero M.L., Way E.L. Effect of morphine on calcium uptake by lysed synaptosomes. J. Pharmacol. Exp. Ther. 211:1979;370-374.
15. Harris R.A., Yamamoto H., Loh H.H., Way E.L. Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinence. Life Sci. 20:1977;501-505.
16. Klee W.A., Streaty R.A. Narcotic receptor sites in morphine-dependent rats. Nature. 248:1974;61-63.
17. Lutfy K., Yoburn B.C. The role of opioid receptor density in morphine tolerance. J. Pharmacol. Exp. Ther. 256:1991;575-580.
18. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur. J. Pharmacol. 352:1998;189-197.
19. Millan M.J., Morris B.J., Herz A. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. J. Pharmacol. Exp. Ther. 247:1988;721-728.
20. 2+ channel blockers. Eur. J. Pharmacol. 217:1992;137-141.
21. Morris B.J., Millan M.J., Herz A. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. J. Pharmacol. Exp. Ther. 247:1988;729-736.
22. Puttfarcken P.S., Cox B.M. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45:1989;1937-1942.
23. Schnur P., Espinoza M., Flores R., Ortiz S., Vallejos S., Wainwright M. Blocking naloxone-precipitated withdrawal in rats and hamsters. Pharmacol. Biochem. Behav. 43:1992;1093-1098.
24. Sehba F., Duttaroy A., Shah S., Chen B., Carroll J., Yoburn B.C. In vivo homologous regulation of mu-opioid receptor gene expression in the mouse. Eur. J. Pharmacol. 339:1997;33-41.
25. Tempel A., Gardner E.L., Zukin R.S. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J. Pharmacol. Exp. Ther. 232:1985;439-444.
26. Yamamoto H., Harris R.A., Loh H.H., Way E.L. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J. Pharmacol. Exp. Ther. 205:1978;255-264.
27. Yoburn B.C., Goodman R.R., Cohen A.H., Pasternak G.W., Inturrisi C.E. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sci. 36:1985;2325-2332.
28. Yoburn B.C., Nunes F.A., Adler B., Pasternak G.W., Inturrisi C.E. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse. J. Pharmacol. Exp. Ther. 239:1986;132-135.
29. Yoburn B.C., Paul D., Azimuddin S., Lutfy K., Sierra V. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia. Brain Res. 485:1989;176-178.
30. Yoburn B.C., Sierra V., Lutfy K. Chronic opioid antagonist treatment. Assessment of receptor upregulation Eur. J. Pharmacol. 170:1989;193-200.
31. Yoburn B.C., Billings B., Duttaroy A. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265:1993;314-320.
32. Yoburn B.C., Shah S., Chan K., Duttaroy A., Davis T. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment. Relationship to receptor selectivity Pharmacol. Biochem. Behav. 51:1995;535-539.
33. Zukin R.S., Sugarman J.R., Fitz-Syage M.L., Gardner E.L., Zukin S.R., Gintzler A.R. Naltrexone-induced opiate receptor supersensitivity. Brain Res. 245:1982;285-292.
34. Zukin R.S., Temple A. Neurochemical correlates of opiate receptor regulation. Biochem. Pharmacol. 35:1986;1623-1627.